Literature DB >> 22266724

Differential sensitivity of RIP3-proficient and deficient murine fibroblasts to camptothecin anticancer drugs.

Jin-xue He, Ying-qing Wang, Jian-ming Feng, Jia-xin Li, Lei Xu, Xiao-hua Li, Wei Wang, Xia-juan Huan, Yi Jiang, Bing Yu, Guang Chen, Ze-hong Miao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266724      PMCID: PMC4077140          DOI: 10.1038/aps.2012.1

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  11 in total

1.  Multiple death pathways in TNF-treated fibroblasts: RIP3- and RIP1-dependent and independent routes.

Authors:  Duan-Wu Zhang; Min Zheng; Jing Zhao; Yuan-Yue Li; Zhe Huang; Zhu Li; Jiahuai Han
Journal:  Cell Res       Date:  2011-01-04       Impact factor: 25.617

Review 2.  Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy.

Authors:  S Fulda; K-M Debatin
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

3.  Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity.

Authors:  Jennifer V Lu; Brian M Weist; Bram J van Raam; Brett S Marro; Long V Nguyen; Prathna Srinivas; Bryan D Bell; Keith A Luhrs; Thomas E Lane; Guy S Salvesen; Craig M Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

Review 4.  Molecular mechanisms of necroptosis: an ordered cellular explosion.

Authors:  Peter Vandenabeele; Lorenzo Galluzzi; Tom Vanden Berghe; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-08       Impact factor: 94.444

5.  Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins.

Authors:  Min Huang; Ze-Hong Miao; Hong Zhu; Yu-Jun Cai; Wei Lu; Jian Ding
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

Review 6.  Mechanisms of resistance to topoisomerase I-targeting drugs.

Authors:  Zeshaan A Rasheed; Eric H Rubin
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

7.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

8.  Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

Authors:  Sudan He; Lai Wang; Lin Miao; Tao Wang; Fenghe Du; Liping Zhao; Xiaodong Wang
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

9.  Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis.

Authors:  Andrew Oberst; Christopher P Dillon; Ricardo Weinlich; Laura L McCormick; Patrick Fitzgerald; Cristina Pop; Razq Hakem; Guy S Salvesen; Douglas R Green
Journal:  Nature       Date:  2011-03-02       Impact factor: 49.962

10.  RIP3 mediates the embryonic lethality of caspase-8-deficient mice.

Authors:  William J Kaiser; Jason W Upton; Alyssa B Long; Devon Livingston-Rosanoff; Lisa P Daley-Bauer; Razqallah Hakem; Tamara Caspary; Edward S Mocarski
Journal:  Nature       Date:  2011-03-02       Impact factor: 49.962

View more
  2 in total

1.  RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation.

Authors:  Can Lu; Li-Yan Zhou; Hui-Jun Xu; Xing-Yu Chen; Zhong-Sheng Tong; Xiao-Dong Liu; Yong-Sheng Jia; Yue Chen
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

2.  The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury.

Authors:  J-X Li; J-M Feng; Y Wang; X-H Li; X-X Chen; Y Su; Y-Y Shen; Y Chen; B Xiong; C-H Yang; J Ding; Z-H Miao
Journal:  Cell Death Dis       Date:  2014-06-05       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.